💊Exclusive Patent License Notice for CAR Technology by NIH
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents applications listed in the Supplementary Information section of this notice to Capstan Therapeutics, Inc. (Capstan), a company located in San Diego, California, the United States of America.
Learn More🏥NIH Announces Closed Meetings for Grant Review Applications
The National Institutes of Health has issued a notice regarding upcoming closed meetings held by the Center for Scientific Review to evaluate grant applications. These meetings, scheduled virtually from August 5 to 12, 2025, will focus on diverse topics related to health and research, including immunology, neurodevelopment, and substance use disorders.
Learn More💰NIH Center for Scientific Review
The Department of Health and Human Services announces closed meetings by the National Institutes of Health's Center for Scientific Review. These meetings aim to evaluate grant applications and contract proposals related to scientific innovation and public health, with specific agendas scheduled for discussion.
Learn More🏥NIH Grant Evaluations
The Department of Health and Human Services announces closed meetings of the Center for Scientific Review for evaluating grant applications. These meetings, including virtual formats, aim to assess proposals in various biomedical fields, emphasizing the importance of confidentiality regarding sensitive and personal information related to the applications.
Learn More💰NIH Announces Closed Meetings for Grant Evaluations in 2025
The Department of Health and Human Services announces closed meetings of the National Institutes of Health for evaluating grant applications related to various health research topics. These meetings, occurring in July and August 2025, will facilitate discussions on proprietary and confidential aspects of proposed research projects.
Learn More💼NIH Center for Scientific Review Meetings on Grant Evaluation
The Department of Health and Human Services announces closed meetings of the Center for Scientific Review to evaluate grant applications for various health-related research projects. These meetings, set to be held virtually, are crucial for organizations seeking funding from the NIH, as confidential discussions around grant proposals will occur.
Learn More💵NIH Closed Meetings for Grant Applications in HIV Research
The NIH announces closed meetings for the Center for Scientific Review to evaluate grant applications related to HIV comorbidities and innovative clinical trials. These discussions, occurring virtually, will involve confidential information pertaining to trade secrets and personal data, underscoring the sensitive nature of the grant application evaluations.
Learn More🩺Notice of Eunice Kennedy Shriver Meeting on Child Health Grants
The notice announces a public meeting of the Board of Scientific Counselors at the Eunice Kennedy Shriver National Institute of Child Health and Human Development. It details the agenda, which includes the evaluation of grant applications and discussions on research organization, while providing contact information for special accommodations and further inquiries.
Learn More🧬NIH Center for Scientific Review
The Department of Health and Human Services announces closed meetings for the Center for Scientific Review to evaluate grant applications. These meetings will be conducted virtually and involve various special emphasis panels focused on diverse fields, including musculoskeletal and dental sciences. Contact information for scientific review officers is provided for further inquiries.
Learn More💉NIH Proposes New Intellectual Property Policy for Cancer Research
The National Cancer Institute, an Institute of the National Institutes of Health, Department of Health and Human Services, Division of Cancer Prevention (DCP) is seeking comments on instituting a standard policy on Intellectual Property (IP) developed by certain funding recipients under NCI DCP funding agreements. This standard policy is entitled "The DIVISION OF CANCER PREVENTION INTELLECTUAL PROPERTY OPTION TO COLLABORATORS (IP Option)." The proposed policy, if finalized, shall apply to entities that conduct DCP-funded clinical studies under funding agreements which involve an NCI collaborator that provides its proprietary agent or technology for the DCP-supported studies where this IP Option is included as a term of applicable existing and future funding agreements.
Learn More